Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Geroscience ; 46(3): 3429-3443, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38441802

ABSTRACT

Epigenetic aging clocks are computational models that predict age using DNA methylation information. Initially, first-generation clocks were developed to make predictions using CpGs that change with age. Over time, next-generation clocks were created using CpGs that relate to both age and health. Since existing next-generation clocks were constructed in blood, we sought to develop a next-generation clock optimized for prediction in cheek swabs, which are non-invasive and easy to collect. To do this, we collected MethylationEPIC data as well as lifestyle and health information from 8045 diverse adults. Using a novel simulated annealing approach that allowed us to incorporate lifestyle and health factors into training as well as a combination of CpG filtering, CpG clustering, and clock ensembling, we constructed CheekAge, an epigenetic aging clock that has a strong correlation with age, displays high test-retest reproducibility across replicates, and significantly associates with a plethora of lifestyle and health factors, such as BMI, smoking status, and alcohol intake. We validated CheekAge in an internal dataset and multiple publicly available datasets, including samples from patients with progeria or meningioma. In addition to exploring the underlying biology of the data and clock, we provide a free online tool that allows users to mine our methylomic data and predict epigenetic age.


Subject(s)
Aging , Epigenesis, Genetic , Humans , Reproducibility of Results , CpG Islands , Aging/genetics , Life Style
2.
Front Nutr ; 11: 1359176, 2024.
Article in English | MEDLINE | ID: mdl-38476603

ABSTRACT

NAD+, a pivotal coenzyme central to metabolism, exhibits a characteristic decline with age. In mice, NAD+ levels can be elevated via treatment with apigenin, a natural flavonoid that inhibits the NAD+-consuming glycoprotein CD38. In animal models, apigenin positively impacts both sleep and longevity. For example, apigenin improves learning and memory in older mice, reduces tumor proliferation in a mouse xenograft model of triple-negative breast cancer, and induces sedative effects in mice and rats. Moreover, apigenin elongates survival in fly models of neurodegenerative disease and apigenin glycosides increase lifespan in worms. Apigenin's therapeutic potential is underscored by human clinical studies using chamomile extract, which contains apigenin as an active ingredient. Collectively, chamomile extract has been reported to alleviate anxiety, improve mood, and relieve pain. Furthermore, dietary apigenin intake positively correlates with sleep quality in a large cohort of adults. Apigenin's electron-rich flavonoid structure gives it strong bonding capacity to diverse molecular structures across receptors and enzymes. The effects of apigenin extend beyond CD38 inhibition, encompassing agonistic and antagonistic modulation of various targets, including GABA and inflammatory pathways. Cumulatively, a large body of evidence positions apigenin as a unique molecule capable of influencing both aging and sleep. Further studies are warranted to better understand apigenin's nuanced mechanisms and clinical potential.

3.
Cell Rep ; 35(6): 109123, 2021 05 11.
Article in English | MEDLINE | ID: mdl-33979604

ABSTRACT

Dopaminergic projections exert widespread influence over multiple brain regions and modulate various behaviors including movement, reward learning, and motivation. It is increasingly appreciated that dopamine neurons are heterogeneous in their gene expression, circuitry, physiology, and function. Current approaches to target dopamine neurons are largely based on single gene drivers, which either label all dopamine neurons or mark a subset but concurrently label non-dopaminergic neurons. Here, we establish a mouse line with Flpo recombinase expressed from the endogenous Slc6a3 (dopamine active transporter [DAT]) locus. DAT-P2A-Flpo mice can be used together with Cre-expressing mouse lines to efficiently and selectively label dopaminergic subpopulations using Cre/Flp-dependent intersectional strategies. We demonstrate the utility of this approach by generating DAT-P2A-Flpo;NEX-Cre mice that specifically label Neurod6-expressing dopamine neurons, which project to the nucleus accumbens medial shell. DAT-P2A-Flpo mice add to a growing toolbox of genetic resources that will help parse the diverse functions mediated by dopaminergic circuits.


Subject(s)
Dopamine Plasma Membrane Transport Proteins/metabolism , Dopaminergic Neurons/metabolism , Animals , Cell Line , Humans , Mice
4.
Cell Metab ; 33(3): 499-512.e6, 2021 03 02.
Article in English | MEDLINE | ID: mdl-33596409

ABSTRACT

Obesity is a major risk factor for adverse outcomes in breast cancer; however, the underlying molecular mechanisms have not been elucidated. To investigate the role of crosstalk between mammary adipocytes and neoplastic cells in the tumor microenvironment (TME), we performed transcriptomic analysis of cancer cells and adjacent adipose tissue in a murine model of obesity-accelerated breast cancer and identified glycine amidinotransferase (Gatm) in adipocytes and Acsbg1 in cancer cells as required for obesity-driven tumor progression. Gatm is the rate-limiting enzyme in creatine biosynthesis, and deletion in adipocytes attenuated obesity-driven tumor growth. Similarly, genetic inhibition of creatine import into cancer cells reduced tumor growth in obesity. In parallel, breast cancer cells in obese animals upregulated the fatty acyl-CoA synthetase Acsbg1 to promote creatine-dependent tumor progression. These findings reveal key nodes in the crosstalk between adipocytes and cancer cells in the TME necessary for obesity-driven breast cancer progression.


Subject(s)
Breast Neoplasms/pathology , Cell Communication/physiology , Creatine/metabolism , Obesity/pathology , Adipose Tissue/cytology , Adipose Tissue/metabolism , Amidinotransferases/deficiency , Amidinotransferases/genetics , Amidinotransferases/metabolism , Animals , Cell Line, Tumor , Coenzyme A Ligases/genetics , Coenzyme A Ligases/metabolism , Diet, High-Fat , Female , Humans , Membrane Transport Proteins/chemistry , Membrane Transport Proteins/genetics , Membrane Transport Proteins/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , RNA Interference , RNA, Small Interfering/metabolism , Tumor Microenvironment
5.
Nat Med ; 27(1): 58-65, 2021 01.
Article in English | MEDLINE | ID: mdl-33398160

ABSTRACT

White fat stores excess energy, whereas brown and beige fat are thermogenic and dissipate energy as heat. Thermogenic adipose tissues markedly improve glucose and lipid homeostasis in mouse models, although the extent to which brown adipose tissue (BAT) influences metabolic and cardiovascular disease in humans is unclear1,2. Here we retrospectively categorized 134,529 18F-fluorodeoxyglucose positron emission tomography-computed tomography scans from 52,487 patients, by presence or absence of BAT, and used propensity score matching to assemble a study cohort. Scans in the study population were initially conducted for indications related to cancer diagnosis, treatment or surveillance, without previous stimulation. We report that individuals with BAT had lower prevalences of cardiometabolic diseases, and the presence of BAT was independently correlated with lower odds of type 2 diabetes, dyslipidemia, coronary artery disease, cerebrovascular disease, congestive heart failure and hypertension. These findings were supported by improved blood glucose, triglyceride and high-density lipoprotein values. The beneficial effects of BAT were more pronounced in individuals with overweight or obesity, indicating that BAT might play a role in mitigating the deleterious effects of obesity. Taken together, our findings highlight a potential role for BAT in promoting cardiometabolic health.


Subject(s)
Adipose Tissue, Brown/metabolism , Cardiovascular Diseases/metabolism , Diabetes Mellitus, Type 2/metabolism , Blood Glucose/metabolism , Dyslipidemias/metabolism , Fluorodeoxyglucose F18/metabolism , Humans , Positron Emission Tomography Computed Tomography/methods , Retrospective Studies
6.
Circ Res ; 126(5): 619-632, 2020 02 28.
Article in English | MEDLINE | ID: mdl-31914850

ABSTRACT

RATIONALE: Remodeling of the vessel wall and the formation of vascular networks are dynamic processes that occur during mammalian embryonic development and in adulthood. Plaque development and excessive neointima formation are hallmarks of atherosclerosis and vascular injury. As our understanding of these complex processes evolves, there is a need to develop new imaging techniques to study underlying mechanisms. OBJECTIVE: We used tissue clearing and light-sheet microscopy for 3-dimensional (3D) profiling of the vascular response to carotid artery ligation and induction of atherosclerosis in mouse models. METHODS AND RESULTS: Adipo-Clear and immunolabeling in combination with light-sheet microscopy were applied to image carotid arteries and brachiocephalic arteries, allowing for 3D reconstruction of vessel architecture. Entire 3D neointima formations with different geometries were observed within the carotid artery and scored by volumetric analysis. Additionally, we identified a CD31-positive adventitial plexus after ligation of the carotid artery that evolved and matured over time. We also used this method to characterize plaque extent and composition in the brachiocephalic arteries of ApoE-deficient mice on high-fat diet. The plaques exhibited inter-animal differences in terms of plaque volume, geometry, and ratio of acellular core to plaque volume. A 3D reconstruction of the endothelium overlying the plaque was also generated. CONCLUSIONS: We present a novel approach to characterize vascular remodeling in adult mice using Adipo-Clear in combination with light-sheet microscopy. Our method reconstructs 3D neointima formation after arterial injury and allows for volumetric analysis of remodeling, in addition to revealing angiogenesis and maturation of a plexus surrounding the carotid artery. This method generates complete 3D reconstructions of atherosclerotic plaques and uncovers their volume, geometry, acellular component, surface, and spatial position within the brachiocephalic arteries. Our approach may be used in a number of mouse models of cardiovascular disease to assess vessel geometry and volume. Visual Overview: An online visual overview is available for this article.


Subject(s)
Carotid Arteries/diagnostic imaging , Imaging, Three-Dimensional/methods , Neovascularization, Physiologic , Optical Imaging/methods , Plaque, Atherosclerotic/diagnostic imaging , Animals , Apolipoproteins E/genetics , Biological Variation, Population , Carotid Arteries/pathology , Carotid Arteries/physiology , Diet, High-Fat/adverse effects , Imaging, Three-Dimensional/standards , Mice , Mice, Inbred C57BL , Neointima/diagnostic imaging , Neointima/pathology , Optical Imaging/standards , Plaque, Atherosclerotic/etiology , Vascular Remodeling
7.
eNeuro ; 5(3)2018.
Article in English | MEDLINE | ID: mdl-30135866

ABSTRACT

Midbrain dopamine neurons project to numerous targets throughout the brain to modulate various behaviors and brain states. Within this small population of neurons exists significant heterogeneity based on physiology, circuitry, and disease susceptibility. Recent studies have shown that dopamine neurons can be subdivided based on gene expression; however, the extent to which genetic markers represent functionally relevant dopaminergic subpopulations has not been fully explored. Here we performed single-cell RNA-sequencing of mouse dopamine neurons and validated studies showing that Neurod6 and Grp are selective markers for dopaminergic subpopulations. Using a combination of multiplex fluorescent in situ hybridization, retrograde labeling, and electrophysiology in mice of both sexes, we defined the anatomy, projection targets, physiological properties, and disease vulnerability of dopamine neurons based on Grp and/or Neurod6 expression. We found that the combinatorial expression of Grp and Neurod6 defines dopaminergic subpopulations with unique features. Grp+/Neurod6+ dopamine neurons reside in the ventromedial VTA, send projections to the medial shell of the nucleus accumbens, and have noncanonical physiological properties. Grp+/Neurod6- dopamine neurons are found in the VTA as well as in the ventromedial portion of the SNc, where they project selectively to the dorsomedial striatum. Grp-/Neurod6+ dopamine neurons represent a smaller VTA subpopulation, which is preferentially spared in a 6-OHDA model of Parkinson's disease. Together, our work provides detailed characterization of Neurod6 and Grp expression in the midbrain and generates new insights into how these markers define functionally relevant dopaminergic subpopulations.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Dopaminergic Neurons/physiology , Gastrin-Releasing Peptide/metabolism , Mesencephalon/metabolism , Nerve Tissue Proteins/metabolism , Animals , Dopaminergic Neurons/cytology , Dopaminergic Neurons/metabolism , Female , In Situ Hybridization, Fluorescence , Male , Mesencephalon/cytology , Mice, Inbred C57BL , Neural Pathways/cytology , Neural Pathways/metabolism , Nucleus Accumbens/cytology , Sequence Analysis, RNA , Ventral Tegmental Area/cytology , Ventral Tegmental Area/pathology
8.
Proc Natl Acad Sci U S A ; 114(11): 2813-2818, 2017 03 14.
Article in English | MEDLINE | ID: mdl-28242676

ABSTRACT

We have designed, synthesized, and applied a rhodol-based chromophore to a molecular wire-based platform for voltage sensing to achieve fast, sensitive, and bright voltage sensing using two-photon (2P) illumination. Rhodol VoltageFluor-5 (RVF5) is a voltage-sensitive dye with improved 2P cross-section for use in thick tissue or brain samples. RVF5 features a dichlororhodol core with pyrrolidyl substitution at the nitrogen center. In mammalian cells under one-photon (1P) illumination, RVF5 demonstrates high voltage sensitivity (28% ΔF/F per 100 mV) and improved photostability relative to first-generation voltage sensors. This photostability enables multisite optical recordings from neurons lacking tuberous sclerosis complex 1, Tsc1, in a mouse model of genetic epilepsy. Using RVF5, we show that Tsc1 KO neurons exhibit increased activity relative to wild-type neurons and additionally show that the proportion of active neurons in the network increases with the loss of Tsc1. The high photostability and voltage sensitivity of RVF5 is recapitulated under 2P illumination. Finally, the ability to chemically tune the 2P absorption profile through the use of rhodol scaffolds affords the unique opportunity to image neuronal voltage changes in acutely prepared mouse brain slices using 2P illumination. Stimulation of the mouse hippocampus evoked spiking activity that was readily discerned with bath-applied RVF5, demonstrating the utility of RVF5 and molecular wire-based voltage sensors with 2P-optimized fluorophores for imaging voltage in intact brain tissue.


Subject(s)
Brain/diagnostic imaging , Epilepsy/diagnosis , Voltage-Sensitive Dye Imaging/methods , Xanthones/chemistry , Animals , Brain/pathology , Disease Models, Animal , Epilepsy/genetics , Humans , Mice , Neurons/pathology , Photons , Tuberous Sclerosis Complex 1 Protein , Tumor Suppressor Proteins/chemistry , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/isolation & purification
9.
Paediatr Anaesth ; 25(6): 595-602, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25565164

ABSTRACT

BACKGROUND AND OBJECTIVES: Ophthalmic arterial chemosurgery for retinoblastoma has been associated with intraoperative decreases in respiratory compliance. Through the analysis of data from computerized records, we objectively defined severe respiratory compliance events and correlated them with demographic and clinical information in patients undergoing this procedure. METHODS: Data were collected from ophthalmic arterial chemosurgery cases from 2006 to 2013. Intraoperative PIP, PEEP, TV, SpO2 , and EtCO2 were analyzed. Compliance changes, desaturations, decreases in EtCO2 , and clinical outcomes were assessed. RESULTS: Respiratory compliance decreases with a bimodal distribution. Severe events were defined as exhibiting a minimum compliance decrease of 40%. Seventy-eight of 122 children (64%) experienced a severe compliance event during at least one treatment, and it occurred in 137/468 cases (29%). A subset of 94 children had complete or at least the first three records. The incidence of a severe respiratory compliance event in this subgroup was 17/94 (18%) on the first and 84/261 (32%) on subsequent procedures. The probability of developing a severe respiratory compliance event on a subsequent procedure was 0.40 if the child developed it on the first procedure, 0.30 if he did not; this difference was not significant. The incidence of desaturation below 90% with severe respiratory compliance events was 0.20; the incidence of a 30% drop in EtCO2 was 0.34. No morbidity, no extended recovery, and no admissions were associated with intraoperative severe respiratory compliance events. We found no correlation between history, age, sex, weight or allergies, and intraoperative severe respiratory compliance events. CONCLUSIONS: Here, most patients experienced a severe respiratory compliance event during at least one of their procedures. Overall incidence was 29% and was more likely on subsequent procedures. A severe respiratory compliance event at the initial procedure was poorly predictive of its occurrence on subsequent procedures. No morbidity was associated with intraoperative severe respiratory compliance events.


Subject(s)
Intraoperative Complications/physiopathology , Ophthalmic Artery , Respiratory Mechanics/physiology , Retinal Neoplasms/drug therapy , Retinoblastoma/drug therapy , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Lung Compliance/physiology , Male , Retinal Neoplasms/complications , Retinoblastoma/complications , Retrospective Studies , Severity of Illness Index
10.
J Exp Med ; 211(5): 909-27, 2014 May 05.
Article in English | MEDLINE | ID: mdl-24711581

ABSTRACT

The zinc finger transcriptional repressor Gfi-1b is essential for erythroid and megakaryocytic development in the embryo. Its roles in the maintenance of bone marrow erythropoiesis and thrombopoiesis have not been defined. We investigated Gfi-1b's adult functions using a loxP-flanked Gfi-1b allele in combination with a novel doxycycline-inducible Cre transgene that efficiently mediates recombination in the bone marrow. We reveal strict, lineage-intrinsic requirements for continuous adult Gfi-1b expression at two distinct critical stages of erythropoiesis and megakaryopoiesis. Induced disruption of Gfi-1b was lethal within 3 wk with severely reduced hemoglobin levels and platelet counts. The erythroid lineage was arrested early in bipotential progenitors, which did not give rise to mature erythroid cells in vitro or in vivo. Yet Gfi-1b(-/-) progenitors had initiated the erythroid program as they expressed many lineage-restricted genes, including Klf1/Eklf and Erythropoietin receptor. In contrast, the megakaryocytic lineage developed beyond the progenitor stage in Gfi-1b's absence and was arrested at the promegakaryocyte stage, after nuclear polyploidization, but before cytoplasmic maturation. Genome-wide analyses revealed that Gfi-1b directly regulates a wide spectrum of megakaryocytic and erythroid genes, predominantly repressing their expression. Together our study establishes Gfi-1b as a master transcriptional repressor of adult erythropoiesis and thrombopoiesis.


Subject(s)
Blood Platelets/physiology , Bone Marrow/physiology , Erythrocytes/physiology , Gene Expression Regulation/genetics , Hematopoiesis/physiology , Proto-Oncogene Proteins/metabolism , Repressor Proteins/metabolism , Animals , DNA Primers/genetics , Embryonic Stem Cells/metabolism , Flow Cytometry , Genetic Vectors , Kaplan-Meier Estimate , Mice , Mice, Transgenic , Microarray Analysis , Microscopy, Fluorescence , Mutagenesis , Proto-Oncogene Proteins/genetics , Real-Time Polymerase Chain Reaction , Repressor Proteins/genetics
11.
Vision Res ; 94: 41-50, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24216007

ABSTRACT

Slant is the degree to which a surface recedes or slopes away from the observer about the horizontal axis. The perception of surface slant may be derived from static monocular cues, including linear perspective and foreshortening, applied to single shapes or to multi-element textures. It is still unclear the extent to which color vision can use these cues to determine slant in the absence of achromatic contrast. Although previous demonstrations have shown that some pictures and images may lose their depth when presented at isoluminance, this has not been tested systematically using stimuli within the spatio-temporal passband of color vision. Here we test whether the foreshortening cue from surface compression (change in the ratio of width to length) can induce slant perception for single shapes for both color and luminance vision. We use radial frequency patterns with narrowband spatio-temporal properties. In the first experiment, both a manual task (lever rotation) and a visual task (line rotation) are used as metrics to measure the perception of slant for achromatic, red-green isoluminant and S-cone isolating stimuli. In the second experiment, we measure slant discrimination thresholds as a function of depicted slant in a 2AFC paradigm and find similar thresholds for chromatic and achromatic stimuli. We conclude that both color and luminance vision can use the foreshortening of a single surface to perceive slant, with performances similar to those obtained using other strong cues for slant, such as texture. This has implications for the role of color in monocular 3D vision, and the cortical organization used in 3D object perception.


Subject(s)
Color Perception/physiology , Depth Perception/physiology , Form Perception/physiology , Vision, Monocular/physiology , Adult , Analysis of Variance , Cues , Discrimination, Psychological , Humans , Lighting , Photic Stimulation/methods , Sensory Thresholds/physiology
12.
Exp Brain Res ; 215(3-4): 293-305, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22006271

ABSTRACT

Achromatic visual function in primates is distributed between two pathways from retina to cortex, the parvocellular and the magnocellular. The relative contribution of these to human achromatic vision is controversial and largely unknown. Here, we use an optic neuritis (ON) model to investigate the effects of a severe loss of parvocellular function on human contrast sensitivity. In our first experiment, we use Gabor stimuli (0.5 cpd, 2 Hz) to show that, compared to normal control eyes, ON causes selective deficits in the two chromatic, cone opponent pathways, with L/M cone opponency affected more than S cone opponency, and a relative sparing of achromatic function. Since L/M cone opponency is carried exclusively by the midget ganglion cells of the parvocellular pathway, this demonstrates a selective deficit of parvocellular function. In a second experiment, we report on two subjects who have lost all L/M cone opponent response in both eyes, indicating a severe loss of parvocellular function. We measure the spatial and temporal contrast sensitivity functions of their remaining achromatic vision, compared with a normal control group, to determine the selectivity of the visual deficit caused by the differential parvocellular loss, and assess the relative contributions of the parvocellular and magnocellular pathways to achromatic contrast sensitivity. We find that parvocellular function contributes selectively at mid- to high spatial frequencies (at low temporal frequencies), whereas magnocellular function determines contrast sensitivity over a very broad temporal frequency range (at low spatial frequencies). Our data bear a striking resemblance to results obtained from primate parvocellular lesions.


Subject(s)
Contrast Sensitivity/physiology , Models, Neurological , Optic Neuritis/physiopathology , Retinal Ganglion Cells/physiology , Vision, Low/physiopathology , Visual Pathways/physiopathology , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Optic Neuritis/diagnosis , Severity of Illness Index , Vision, Low/diagnosis , Vision, Low/etiology
13.
Drug Metab Dispos ; 39(3): 498-509, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21098646

ABSTRACT

Cumene is a high-production volume chemical that has been shown to be a central nervous system depressant and has been implicated as a long-term exposure carcinogen in experimental animals. The absorption, distribution, metabolism, and excretion of [(14)C]cumene (isopropylbenzene) was studied in male rats and mice of both sexes after oral or intravenous administration. In both species and sexes, urine accounted for the majority of the excretion (typically ≥ 70%) by oral and intravenous administration. Enterohepatic circulation of cumene and/or its metabolites was indicated because 37% of the total dose was excreted in bile in bile duct-cannulated rats with little excreted in normal rats. The highest tissue (14)C levels in rats were observed in adipose tissue, liver, and kidney with no accumulation observed after repeat dosing up to 7 days. In contrast, mice contained the highest concentrations of (14)C at 24 h after dosing in the liver, kidney, and lung, with repeat dosing accumulation of (14)C observed in these tissues as well as in the blood, brain, heart, muscle, and spleen. The metabolites in the expired air, urine, bile, and microsomes were characterized with 16 metabolites identified. The volatile organics in the expired air comprised mainly cumene and up to 4% α-methylstyrene. The major urinary and biliary metabolite was 2-phenyl-2-propanol glucuronide, which corresponded with the main microsomal metabolite being 2-phenyl-2-propanol.


Subject(s)
Benzene Derivatives/pharmacokinetics , Carcinogens/pharmacokinetics , Central Nervous System Depressants/pharmacokinetics , Administration, Oral , Animals , Benzene Derivatives/administration & dosage , Benzene Derivatives/metabolism , Benzene Derivatives/urine , Bile/metabolism , Carcinogens/administration & dosage , Carcinogens/metabolism , Central Nervous System Depressants/administration & dosage , Central Nervous System Depressants/metabolism , Central Nervous System Depressants/urine , Female , Glucuronides/metabolism , Injections, Intravenous , Intestinal Absorption , Kidney/metabolism , Liver/metabolism , Lung/metabolism , Male , Mice , Microsomes/metabolism , Organ Specificity , Propanols/metabolism , Rats , Rats, Inbred F344 , Sex Characteristics , Species Specificity , Styrenes/chemistry , Styrenes/metabolism , Tissue Distribution
14.
Mol Imaging Biol ; 12(3): 316-24, 2010 Jun.
Article in English | MEDLINE | ID: mdl-19779897

ABSTRACT

INTRODUCTION: The development of molecular probes based on novel engineered protein constructs is under active investigation due to the great potential of this generalizable strategy for imaging a variety of tumor targets. DISCUSSION: In this report, human epidermal growth factor receptor type 2 (HER2)-binding Affibody molecules were radiolabeled with (64)Cu and their imaging ability was further evaluated in tumor mice models to understand the promise and limitations of such probes. The anti-HER2 Affibody molecules in monomeric (Z(HER2:477)) and dimeric [(Z(HER2:477))(2)] forms were site specifically modified with the maleimide-functionalized chelator, 1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid)-10-acetate mono (N-ethylmaleimide amide) (Mal-DOTA). The resulting DOTA-Affibody conjugates were radiolabeled with (64)Cu and evaluated in nude mice bearing subcutaneous SKOV3 tumors. Biodistribution experiments showed that tumor uptake values of (64)Cu-DOTA-Z(HER2:477) and (64)Cu-DOTA-(Z(HER2:477))(2) were 6.12 +/- 1.44% and 1.46 +/- 0.50% ID/g, respectively, in nude mice (n = 3 each) at 4 h postinjection. Moreover, (64)Cu-labeled monomer exhibited significantly higher tumor/blood ratio than that of radiolabeled dimeric counterpart at all time points examined in this study. MicroPET imaging of (64)Cu-DOTA-Z(HER2:477) in SKOV3 tumor mice clearly showed good and specific tumor localization. This study demonstrates that (64)Cu-labeled Z(HER2:477) is a promising targeted molecular probe for imaging HER2 receptor expression in living mice. Further work is needed to improve the excretion properties, hence dosimetry and imaging efficacy, of the radiometal-based probe.


Subject(s)
Copper Radioisotopes , Neoplasms/diagnosis , Positron-Emission Tomography/methods , Receptor, ErbB-2/metabolism , Recombinant Fusion Proteins , Animals , Blotting, Western , Cell Line, Tumor , Copper Radioisotopes/pharmacokinetics , Humans , Mice , Organometallic Compounds/chemical synthesis , Organometallic Compounds/chemistry , Organometallic Compounds/pharmacokinetics , Recombinant Fusion Proteins/pharmacokinetics , Staining and Labeling , Time Factors , Tissue Distribution , Xenograft Model Antitumor Assays
15.
Inorg Chem ; 41(24): 6181-3, 2002 Dec 02.
Article in English | MEDLINE | ID: mdl-12444754

ABSTRACT

N-(2-Mercaptoethyl)picolylamine (MEPAH) was studied as a potentially biologically relevant ligand for the "fac-[M(CO)(3)](+)" core (M = Re, (99)Tc, (99m)Tc). To this end, the complex Re(CO)(3)(MEPA) was synthesized. The reaction of MEPAH with fac-[Re(CO)(3)(MeCN)(3)](+) took place over the course of seconds, showing the high affinity possessed by this ligand for the "fac-[Re(CO)(3)](+)" core. A single-crystal X-ray diffraction study was performed confirming the nature of Re(CO)(3)(MEPA), a rare mononuclear rhenium(I) thiolate complex. Additional exploration into derivatization of the ligand backbone has afforded the analogous N-ethyl complex, Re(CO)(3)(MEPA-NEt). The high affinity of the ligand for the metal coupled with the ease of its derivatization implies that utilization of this ligand system for the purposes of (99m)Tc-radiopharmaceutical development is promising.


Subject(s)
Mercaptoethylamines/chemistry , Sulfur Compounds/chemistry , Binding Sites , Catalysis , Crystallography, X-Ray , Ligands , Molecular Conformation , Molecular Structure , Organotechnetium Compounds , Radiopharmaceuticals
SELECTION OF CITATIONS
SEARCH DETAIL
...